Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2024 | Leveraging agents derived from natural products in modern oncology

Coy Heldermon, MD, PhD, University of Florida, Gainesville, FL, comments on the enduring role of natural products in oncology, as well as the shift towards targeted therapies and the de-escalation of toxic treatments. There is additional potential for further investigating natural agents to modulate inflammatory responses and reduce treatment-related toxicities, aligning with the goals of precision medicine and improved cancer care. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.